Compare · QS vs TMO
QS vs TMO
Side-by-side comparison of QuantumScape Corporation (QS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- QS operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $248.91B, about 40.8x QS ($6.09B).
- TMO has been more active in the news (7 items in the past 4 weeks vs 3 for QS).
- TMO has more recent analyst coverage (25 ratings vs 22 for QS).
- Company
- QuantumScape Corporation
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $6.09B
- $248.91B
- 1M return
- -21.53%
- -
- 1Y return
- -73.84%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 7
- Recent ratings
- 22
- 25
QuantumScape Corporation
QuantumScape Corporation, a development stage company, engages in the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest QS
- QuantumScape Announces Timing of Third Quarter 2026 Business Results and Webcast
- QuantumScape Announces QS PowerBlock for In-Rack Energy Storage in AI Data Centers
- SEC Form 4 filed by QuantumScape Corporation
- CHIEF TECHNOLOGY OFFICER Holme Timothy sold $610,524 worth of shares (120,000 units at $5.09) as part of a pre-agreed trading plan and converted options into 45,000 shares, decreasing direct ownership by 5% to 1,583,075 units (SEC Form 4)
- CHIEF TECHNOLOGY OFFICER Holme Timothy converted options into 12,723 shares and sold $76,516 worth of shares (12,723 units at $6.01) as part of a pre-agreed trading plan (SEC Form 4)
- CHIEF TECHNOLOGY OFFICER Holme Timothy covered exercise/tax liability with 34,086 shares, sold $241,109 worth of shares (41,876 units at $5.76) as part of a pre-agreed trading plan and converted options into 21,531 shares, decreasing direct ownership by 3% to 1,658,075 units (SEC Form 4) (tax withholding)
- CHIEF LEGAL OFFICER Mccarthy Michael O Iii covered exercise/tax liability with 25,709 shares, decreasing direct ownership by 2% to 1,527,774 units (SEC Form 4) (withholding obligation)
- CHIEF DEVELOPMENT OFFICER Singh Mohit covered exercise/tax liability with 34,304 shares, decreasing direct ownership by 2% to 1,737,150 units (SEC Form 4) to cover taxes
- CHIEF FINANCIAL OFFICER Hettrich Kevin covered exercise/tax liability with 31,095 shares, decreasing direct ownership by 2% to 1,785,162 units (SEC Form 4) (tax liability)
- CHIEF EXECUTIVE OFFICER Sivaram Srinivasan covered exercise/tax liability with 81,752 shares, decreasing direct ownership by 2% to 5,078,264 units (SEC Form 4) to satisfy withholding tax
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)